APA (7th ed.) Citation

Wang, X., Chen, Z., Tong, L., Tan, S., Zhou, W., Peng, T., . . . Xu, Y. (2013). Naphthalimides exhibit in vitro antiproliferative and antiangiogenic activities by inhibiting both topoisomerase II (topo II) and receptor tyrosine kinases (RTKs). European Journal of Medicinal Chemistry, 65, 477. https://doi.org/10.1016/j.ejmech.2013.05.002

Chicago Style (17th ed.) Citation

Wang, Xin, et al. "Naphthalimides Exhibit in Vitro Antiproliferative and Antiangiogenic Activities by Inhibiting Both Topoisomerase II (topo II) and Receptor Tyrosine Kinases (RTKs)." European Journal of Medicinal Chemistry 65 (2013): 477. https://doi.org/10.1016/j.ejmech.2013.05.002.

MLA (9th ed.) Citation

Wang, Xin, et al. "Naphthalimides Exhibit in Vitro Antiproliferative and Antiangiogenic Activities by Inhibiting Both Topoisomerase II (topo II) and Receptor Tyrosine Kinases (RTKs)." European Journal of Medicinal Chemistry, vol. 65, 2013, p. 477, https://doi.org/10.1016/j.ejmech.2013.05.002.